Recombinant Putative trans-acting enoyl reductase Rv2449c (Rv2449c)

Shipped with Ice Packs
In Stock

Description

Protein Overview

Rv2449c is annotated as a putative trans-acting enoyl reductase involved in the fatty acid synthesis (FAS-II) pathway. Enoyl reductases catalyze the final step of the elongation cycle, reducing trans-2-enoyl-acyl carrier protein (ACP) to acyl-ACP using NADH or NADPH as a cofactor . Key features include:

PropertyDetails
Gene NameRv2449c
UniProt IDO53176
SpeciesMycobacterium tuberculosis
Expression SystemEscherichia coli (E. coli) with N-terminal His tag
Protein Length419 amino acids (full-length)
Purity>90% (verified by SDS-PAGE)
StorageLyophilized powder in Tris/PBS buffer with 6% trehalose (pH 8.0)
ReconstitutionRequires sterile water; glycerol (5–50%) recommended for long-term storage
Source:

Catalytic Mechanism

Enoyl reductases like Rv2449c typically employ a conserved tyrosine residue (e.g., Y158 in Mtb InhA) to facilitate proton transfer during substrate reduction . Structural studies of related enzymes (e.g., FabI, FabV) suggest a Rossmann fold for NADH binding and a water-mediated protonation pathway .

Role in Mycobacterial Metabolism

  • Fatty Acid Synthesis: Rv2449c is implicated in mycolic acid biosynthesis, essential for Mtb’s cell wall integrity and antibiotic resistance .

  • Regulatory Interactions: Proteins like ClpC1 (a protease unfoldase) modulate Rv2449c levels, indicating its sensitivity to proteostatic stress .

Drug Target Potential

Enoyl reductases are validated targets for antimycobacterial agents (e.g., isoniazid targets InhA, Rv1484) . While Rv2449c’s exact role in drug resistance remains uncharacterized, its structural homology to FabI enzymes suggests potential for inhibitor development .

Comparative Analysis with Other Enoyl Reductases

FeatureRv2449cFabI (InhA)FabV
CofactorLikely NADH/NADPHNADHNADH
StructurePredicted Rossmann foldTetrameric SDR superfamilyMonomeric SDR superfamily
Substrate SpecificityLong-chain enoyl-ACPs (inferred)Long-chain enoyl-ACPsBroad substrate range
InhibitorsUndeterminedIsoniazid, triclosanPT01 (experimental)
Sources:

Research Gaps and Future Directions

  • Mechanistic Studies: The catalytic residues and substrate preferences of Rv2449c require experimental validation.

  • Inhibitor Screening: High-throughput assays using recombinant Rv2449c could identify novel antitubercular compounds .

  • Structural Biology: Cryo-EM or X-ray crystallography would clarify its active-site architecture and cofactor interactions .

Product Specs

Form
Supplied as a lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting to -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Rv2449c; Putative trans-acting enoyl reductase Rv2449c
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-419
Protein Length
full length protein
Species
Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Target Names
Rv2449c
Target Protein Sequence
MTATPREFDIVLYGATGFVGKLTAEYLARAGGDARIALAGRSTQRVLAVREALGESAQTW PILTADASLPSTLQAMAARAQVVVTTVGPYTRYGLPLVAACAAAGTDYADLTGEPMFMRN SIDLYHKQAADTGARIVHACGFDSVPSDLSVYALYHAAREDGAGELTDTNCVVRSFKGGF SGGTIASMLEVLSTASNDPDARRQLSDPYMLSPDRGAEPELGPQPDLPSRRGRRLAPELA GVWTAGFIMAPTNTRIVRRSNALLDWAYGRRFRYSETMSVGSTVLAPVVSVVGGGVGNAM FGLASRYIRLLPRGLVKRVVPKPGTGPSAAARERGYYRIETYTTTTTGARYLARMAQDGD PGYKATSVLLGECGLALALDRDKLSDMRGVLTPAAAMGDALLERLPAAGVSLQTTRLAS
Uniprot No.

Target Background

Database Links

KEGG: mtu:Rv2449c

STRING: 83332.Rv2449c

Protein Families
Saccharopine dehydrogenase family, Enoyl reductase subfamily
Subcellular Location
Cell membrane; Single-pass membrane protein.

Q&A

What is Rv2449c and what are its basic structural properties?

Rv2449c is a putative trans-acting enoyl reductase from Mycobacterium tuberculosis. It is a full-length protein consisting of 419 amino acids (residues 1-419) and can be produced as a recombinant protein with a His-tag using E. coli expression systems . As a putative enoyl reductase, it likely plays a role in mycobacterial fatty acid metabolism, which is crucial for cell wall synthesis and potentially virulence.

The protein structure has not been fully characterized in the available literature, but researchers can express it as a recombinant protein for structural and functional studies. The protein's relatively large size (419 amino acids) suggests it may have multiple domains or complex folding patterns that contribute to its enzymatic activity.

How might Rv2449c relate to the Clp proteolytic system in Mycobacterium tuberculosis?

While direct evidence linking Rv2449c to the Clp proteolytic system is not explicitly stated in the available research, the connection is worth investigating. Mycobacterium tuberculosis possesses a well-orchestrated Clp (caseinolytic protease) proteolytic machinery consisting of two components: a barrel-shaped heterotetradecameric protease core (ClpP1 and ClpP2 subunits) and hexameric ring-like ATP-dependent unfoldases (ClpX or ClpC1) .

The Clp system regulates dosage-sensitive proteins and participates in proteostasis network maintenance. Rv2449c could potentially:

  • Be a substrate of the Clp system, regulated through proteolytic degradation

  • Function in metabolic pathways that intersect with proteins regulated by ClpC1

  • Be part of stress response mechanisms that involve the Clp machinery

Experimental approaches such as knockdown studies of clpC1 combined with proteomics analysis could help identify whether Rv2449c levels are affected by Clp system perturbations.

What functional pathways might involve Rv2449c in Mycobacterium tuberculosis metabolism?

As a putative trans-acting enoyl reductase, Rv2449c likely participates in fatty acid biosynthesis or modification pathways that are essential for mycobacterial cell wall synthesis. While specific pathway information for Rv2449c is not detailed in the available search results, enoyl reductases typically catalyze the final reductive step in fatty acid elongation cycles.

Potential metabolic contexts for Rv2449c include:

  • Mycolic acid biosynthesis, which is crucial for the distinctive mycobacterial cell envelope

  • Fatty acid elongation pathways that contribute to membrane phospholipid synthesis

  • Specialized lipid production involved in virulence or stress responses

Determining the exact metabolic role of Rv2449c would require experimental validation through enzymatic assays, pathway reconstitution, and substrate identification studies.

What expression systems are most effective for producing recombinant Rv2449c protein?

Based on available data, E. coli has been successfully used as an expression host for recombinant His-tagged Rv2449c protein . When designing expression systems for mycobacterial proteins like Rv2449c, researchers should consider:

  • Codon optimization: Adapting the coding sequence to match E. coli codon usage preferences

  • Expression vectors: Selecting appropriate promoters (T7, tac) and fusion tags (His-tag for purification)

  • Host strains: Using specialized E. coli strains designed for recombinant protein expression

  • Induction conditions: Optimizing temperature, inducer concentration, and induction timing

The expression conditions reported for successful production of Rv2449c are summarized in the following table:

ParameterCondition
Host organismE. coli
Protein lengthFull length (1-419 amino acids)
Fusion tagHis-tag
Source speciesMycobacterium tuberculosis
Product formatRecombinant protein

How can CRISPR interference be applied to study the function of Rv2449c?

While the search results don't specifically mention CRISPR interference (CRISPRi) studies of Rv2449c, this approach has been effectively used to study essential genes in Mycobacterium tuberculosis . CRISPRi could be applied to study Rv2449c function through:

  • Conditional gene silencing: Using anhydrotetracycline (ATc)-dependent suppression to achieve fine-tuned control of Rv2449c expression

  • Partial knockdown: Reducing gene expression without completely eliminating it, allowing study of essential genes

  • Time-course experiments: Activating suppression at different growth phases to determine stage-specific functions

  • Phenotypic analysis: Assessing growth rate, morphology, and stress responses upon Rv2449c depletion

A CRISPRi approach for Rv2449c would involve:

  • Designing guide RNAs targeting the Rv2449c promoter or early coding region

  • Constructing a CRISPRi vector with the dCas9 gene and the guide RNA

  • Transforming the vector into Mycobacterium tuberculosis

  • Inducing gene silencing with ATc and monitoring phenotypic changes

This methodology has successfully demonstrated the essentiality of clpC1 in mycobacterial growth and survival in macrophages, with 70-80% suppression achieved after 7 days of treatment with 50 ng/ml ATc .

What proteomics approaches are most suitable for identifying potential interaction partners of Rv2449c?

Based on proteomics methodologies used in mycobacterial research, several approaches could be effective for identifying Rv2449c interaction partners:

  • Isobaric tags for relative and absolute quantitation (iTRAQ)-based LC-MS: This approach has been successfully used to identify proteins that accumulate in clpC1 and clpP2 knockdown strains . A similar approach could identify changes in the proteome upon Rv2449c manipulation.

  • Co-immunoprecipitation with LC-MS/MS analysis: Using antibodies against tagged Rv2449c to pull down protein complexes, followed by mass spectrometry identification.

  • Bacterial two-hybrid systems: Screening for direct protein-protein interactions involving Rv2449c.

  • Proximity-based labeling approaches: Using BioID or APEX2 fusions with Rv2449c to identify proximal proteins in the native environment.

The iTRAQ-based approach used for studying the Clp system identified:

  • 317 proteins accumulated in clpC1 knockdown

  • 359 proteins accumulated in clpP2 knockdown

  • 219 proteins (69%) common to both knockdown strains

This suggests substantial overlap in the substrates processed by different components of the Clp machinery, and similar approaches could reveal functional relationships for Rv2449c.

What statistical approaches are most appropriate for analyzing enzymatic activity data for Rv2449c?

When analyzing enzymatic activity data for Rv2449c or similar proteins, researchers should implement robust statistical approaches that account for variability and experimental limitations. Based on statistical principles outlined in search result , the following approaches are recommended:

  • Descriptive statistics:

    • Measures of central tendency (mean, median, mode) to summarize performance levels

    • Measures of variability (range, variance, standard deviation) to describe data spread

  • Inferential statistics:

    • Null and alternative hypothesis formulation

    • Selection of appropriate statistical tests based on data distribution

    • Determination of statistical significance through p-value calculation

  • Experimental design considerations:

    • Power analysis to determine adequate sample sizes

    • Effect size calculations to quantify the magnitude of observed effects

    • Assessment of Type I (false positive) and Type II (false negative) error rates

The importance of variability cannot be overstated—as noted in search result , when variability is large, measures of central tendency become less reliable guides to representative performance. This principle applies directly to enzymatic assays, where reducing variability is essential for detecting treatment effects.

How should researchers design experiments to minimize variability when studying Rv2449c function?

To minimize variability in experiments involving Rv2449c or similar mycobacterial proteins, researchers should implement several strategies derived from experimental design principles :

  • Control over experimental conditions:

    • Select reliable dependent variables and standardized measurement techniques

    • Provide uniform instructions and standardized experimental procedures

    • Control obtrusive and extraneous experimental stimuli

  • Careful sample preparation:

    • Standardize protein expression and purification protocols

    • Verify protein quality and concentration through multiple methods

    • Prepare reagents fresh and under identical conditions

  • Robust experimental design:

    • Include appropriate technical and biological replicates

    • Randomize sample processing order to avoid systematic bias

    • Use internal standards and calibration curves for quantitative assays

  • Data collection and analysis:

    • Implement consistent data collection procedures

    • Use statistical methods appropriate for the data distribution

    • Apply transformations if necessary to meet statistical assumptions

As noted in search result , "much of this text focuses, directly or indirectly, on procedures for reducing variability—for example, selecting a reliable dependent variable, providing uniform instructions and standardized experimental procedures, and controlling obtrusive and extraneous experimental stimuli."

What experimental controls are crucial when studying the enzymatic activity of Rv2449c?

When studying enzymatic activity of Rv2449c, several critical controls should be included:

  • Negative controls:

    • Reaction mixtures without enzyme (substrate-only controls)

    • Heat-inactivated enzyme preparations

    • Reactions with known inhibitors of similar enzymes

  • Positive controls:

    • Well-characterized enzymes with similar activity

    • Verified enzyme preparations with known activity levels

    • Standard curves with purified reaction products

  • Specificity controls:

    • Substrate specificity tests using related compounds

    • Cofactor dependency tests (NAD+/NADH, metal ions)

    • pH and temperature optima determinations

  • System controls:

    • Empty vector controls when using expression systems

    • Wild-type strain comparisons when using genetic approaches

    • Vehicle controls for any additives or solvents

  • Technical controls:

    • Instrument calibration standards

    • Inter-assay and intra-assay variability assessments

    • Time-course measurements to ensure linearity of the assay

These controls align with the rigorous experimental approaches described for studying essential mycobacterial proteins such as components of the Clp system .

How can researchers investigate the role of Rv2449c in Mycobacterium tuberculosis survival within macrophages?

To investigate Rv2449c's potential role in macrophage survival, researchers can adapt methodologies used for studying the Clp system :

  • Conditional gene silencing approach:

    • Generate CRISPRi-based knockdown strains for Rv2449c

    • Verify knockdown efficiency at the mRNA and protein levels

    • Assess growth in synthetic media before proceeding to infection models

  • Macrophage infection protocol:

    • Infect THP-1 macrophages (or other relevant cell lines) with control and Rv2449c-depleted bacteria

    • Use appropriate multiplicity of infection (MOI), such as 1:2 as used for ClpC1 studies

    • Monitor bacterial survival at multiple time points (days 0, 1, 3, 5, and 7)

  • Quantification methods:

    • Perform CFU plating of macrophage lysates to enumerate viable bacteria

    • Calculate log₁₀ CFU/well at each time point

    • Compare growth trajectories between control and knockdown strains

  • Complementary approaches:

    • Analyze macrophage responses (cytokine production, phagosomal maturation)

    • Assess bacterial stress responses within the intracellular environment

    • Investigate potential metabolic adaptations upon Rv2449c depletion

For reference, in ClpC1 knockdown studies, control Mtb showed substantial growth in THP-1 macrophages (increasing from 3.92 to 5.25 log₁₀ CFU/well over 7 days), while ClpC1-depleted bacteria showed minimal growth (3.79 to 4.24 log₁₀ CFU/well) .

What approaches can identify whether Rv2449c is a substrate of the Clp proteolytic system?

To determine if Rv2449c is a substrate of the Clp proteolytic system, researchers could employ several complementary approaches based on methodologies described for studying Clp substrates :

  • Proteomic analysis of accumulating proteins:

    • Generate conditional knockdown strains of clpC1 and clpP2

    • Perform iTRAQ-based LC-MS analysis of whole-cell lysates

    • Compare protein abundance profiles between control and knockdown strains

    • Identify whether Rv2449c accumulates upon Clp system depletion

  • Direct interaction studies:

    • Express and purify tagged versions of ClpC1 and Rv2449c

    • Perform in vitro pull-down assays to detect direct interactions

    • Use surface plasmon resonance or microscale thermophoresis to quantify binding affinities

  • Degradation assays:

    • Reconstitute the Clp proteolytic system in vitro

    • Monitor degradation of purified Rv2449c in the presence of Clp components

    • Use Western blotting or fluorescence-based assays to quantify degradation rates

  • In vivo stability measurements:

    • Express tagged Rv2449c in wild-type and Clp-depleted mycobacteria

    • Perform protein synthesis inhibition (e.g., with chloramphenicol)

    • Monitor Rv2449c turnover rates in different genetic backgrounds

These approaches could reveal whether Rv2449c is among the proteins regulated by the Clp system, which has been shown to affect numerous proteins involved in intermediary metabolism, respiration, and lipid metabolism .

How does the Clp proteolytic system regulate dosage-sensitive proteins in Mycobacterium tuberculosis, and what implications might this have for Rv2449c research?

The Clp proteolytic system plays a crucial role in regulating dosage-sensitive proteins in Mycobacterium tuberculosis. Search result specifically mentions that "the Clp machinery regulates dosage-sensitive proteins such as the small heat shock protein Hsp20, which exists in a dodecameric conformation."

Key aspects of this regulation include:

  • Proteostasis maintenance:

    • The Clp system helps maintain protein homeostasis by degrading misfolded or damaged proteins

    • It regulates the levels of proteins that may be toxic when overexpressed

    • This process is essential for bacterial survival under normal physiological conditions

  • Targeted protein degradation:

    • The ClpC1 unfoldase recognizes and unfolds specific substrate proteins

    • These unfolded proteins are then transferred to the ClpP1P2 protease core for degradation

    • Substrate recognition may involve specific sequence motifs or structural features

  • Stress response regulation:

    • The Clp system helps bacteria adapt to changing environmental conditions

    • It may regulate the turnover of stress-induced proteins when conditions normalize

    • This function is crucial for mycobacterial survival in the host environment

Implications for Rv2449c research:

If Rv2449c is a dosage-sensitive protein, its levels might be carefully regulated by the Clp system. Proteomics analysis has shown that 69% of proteins that accumulate in clpC1-knockdown strains also accumulate in clpP2-knockdown strains, suggesting substantial overlap in the substrate pools . Among these are proteins involved in intermediary metabolism and respiration (37%), lipid metabolism (24%), and cell wall processes (24%) .

Understanding whether Rv2449c falls into these categories could provide insights into its regulation and functional importance in mycobacterial physiology.

What are the current limitations in studying Rv2449c and other essential mycobacterial proteins?

Several significant challenges exist in studying potentially essential mycobacterial proteins like Rv2449c:

  • Genetic manipulation constraints:

    • If Rv2449c is essential (like ClpC1), direct gene deletion would be lethal

    • Conditional approaches are required but can be technically challenging

    • CRISPRi systems require careful optimization to achieve appropriate levels of suppression

  • Expression and purification challenges:

    • Mycobacterial proteins often have unusual codon usage or require specific folding conditions

    • Obtaining sufficient quantities of properly folded protein for biochemical studies can be difficult

    • Post-translational modifications may differ between heterologous expression systems and native conditions

  • Functional characterization limitations:

    • Enzymatic assays require identification of appropriate substrates

    • In vitro activity may not fully reflect in vivo function

    • Interaction partners in the complex mycobacterial cellular environment may be difficult to identify

  • Physiological relevance assessment:

    • Connecting biochemical activities to physiological roles requires multiple approaches

    • Compensatory mechanisms may mask phenotypes in partial knockdown systems

    • Translation between in vitro, ex vivo, and in vivo models presents challenges

The study of ClpC1 demonstrated how essential genes can be investigated using CRISPRi-based approaches, achieving 70-80% suppression after 7 days of ATc treatment . Similar approaches could be adapted for Rv2449c research.

How can proteomics approaches advance our understanding of Rv2449c function?

Proteomics approaches offer powerful tools for elucidating Rv2449c function, as demonstrated by their successful application to understanding the Clp system :

  • Global protein abundance profiling:

    • iTRAQ-based quantitative proteomics to identify changes upon Rv2449c manipulation

    • Comparison of protein abundance profiles between wild-type and Rv2449c-depleted strains

    • Identification of proteins indirectly affected by Rv2449c function

  • Protein interaction network mapping:

    • Affinity purification coupled with mass spectrometry to identify Rv2449c interactors

    • Proximity-labeling approaches to identify proteins in the same subcellular compartment

    • Cross-linking mass spectrometry to capture transient interactions

  • Post-translational modification analysis:

    • Identification of modifications on Rv2449c that might regulate its activity

    • Assessment of how Rv2449c might affect modification patterns of other proteins

    • Correlation of modifications with specific growth conditions or stress responses

  • Functional classification of affected proteins:

    • Pathway analysis of proteins affected by Rv2449c manipulation

    • Identification of enriched biological processes among differentially abundant proteins

    • Integration with transcriptomic data to understand regulatory networks

The proteomics approach used for ClpC1 studies identified fundamental categories of affected proteins, including those involved in intermediary metabolism and respiration (37%), lipid metabolism (24%), cell wall processes (24%), and unknown functions (27%) . Similar categorization of Rv2449c-dependent proteins could provide crucial insights into its functional role.

What statistical considerations are essential when interpreting contradictory findings about Rv2449c function?

When researchers encounter contradictory findings about Rv2449c function, several statistical considerations derived from search result become essential:

  • Variability assessment:

    • Evaluate the measures of variability in different studies

    • Consider whether high variability might obscure treatment effects

    • As noted, "When variability is large, it is simply more difficult to regard a measure of central tendency as a dependable guide to representative performance"

  • Effect size evaluation:

    • Calculate effect sizes to standardize the magnitude of observed effects

    • Compare effect sizes across studies to identify potential sources of discrepancy

    • Consider whether statistically significant results are also biologically meaningful

  • Statistical power analysis:

    • Assess whether studies had sufficient power to detect effects of interest

    • Evaluate whether negative findings might result from Type II errors

    • Consider sample sizes in relation to expected effect sizes

  • Experimental design comparison:

    • Examine differences in experimental conditions, strains, and methodologies

    • Evaluate control procedures and their appropriateness

    • Consider whether experiments were optimized to reduce "unsystematic variability (random error)"

  • Meta-analytical approach:

    • Systematically compare results across multiple studies

    • Weight findings based on methodological quality and sample size

    • Identify moderator variables that might explain contradictory results

  • Null hypothesis significance testing:

    • Consider the formulation of null and alternative hypotheses

    • Evaluate the appropriateness of statistical tests used

    • Assess whether multiple comparison corrections were applied when necessary

Understanding that "two factors are commonly involved in assessing the effects of an experimental variable: a measure of centrality, such as the mean, median, or proportion; and a measure of variability, such as the standard deviation" is crucial when interpreting contradictory findings about protein function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.